PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15380050-7	2004	The effect of G-CSF, GM-CSF, IL3 and M-CSF on daunorubicin mediated cytotoxicity in K562 cells was measured using the MTT assay.	Daunorubicin	46-58	colony stimulating factor 3	Homo sapiens	14-19	
19036079-5	2009	This was more notable in children who received idarubicin, fludarabine, ara-C, and granulocyte colony-stimulating factor (IDA-FLAG; ara-C = 7590 mg/m2) (5-year TRM 24 +/- 21% CC vs. 6 +/- 6% AA, 6 +/- 7% AC, P = 0.07) as consolidation therapy compared to idarubicin, dexamethasone, cytarabine, thioguanine, etoposide and daunomycin (IDA-DCTER; ara-C = 800 mg/m2) (5-year TRM 15 +/- 20% CC vs. 8 +/- 6% AA, 4 +/- 6% AC; P = 0.29).	Daunorubicin	321-331	colony stimulating factor 3	Homo sapiens	83-120	
18493867-0	2008	Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.	Daunorubicin	92-104	colony stimulating factor 3	Homo sapiens	0-37	
18493867-6	2008	In this study we investigated how G-CSF might influence the sensitivity of leukemic cells to daunorubicin induced cell death using MTT assay, flow cytometry and Western blot analysis.	Daunorubicin	93-105	colony stimulating factor 3	Homo sapiens	34-39	
18493867-7	2008	After pretreatment of KG-1 leukaemic cells with G-CSF a moderate increase in the resistance of these cells to daunorubicin could be observed.	Daunorubicin	110-122	colony stimulating factor 3	Homo sapiens	48-53	
18493867-9	2008	In addition, adjuvant treatment of AML patients with G-CSF in order to prevent neutropenia, or its use in priming regimens might result resistance to daunorubicin.	Daunorubicin	150-162	colony stimulating factor 3	Homo sapiens	53-58	
9685063-11	1998	We conclude that G-CSF and IL-3 augment the effect of daunorubicin on normal hematopoietic progenitor cells.	Daunorubicin	54-66	colony stimulating factor 3	Homo sapiens	17-22	
1699657-5	1990	According to in vitro cytotoxic assay, the sensitivity of G-CSF-stimulated cells to intercalating (daunorubicin) and nonintercalating (etoposide) topo II-targeting drugs increased significantly, whereas no enhancement of sensitivity was observed with an alkylating agent (4-hydroperoxycyclophosphamide).	Daunorubicin	99-111	colony stimulating factor 3	Homo sapiens	58-63	
8599980-9	1996	G-CSF significantly enhanced the cytotoxic effect of daunorubicin, mitoxantrone, etoposide and Ara-C by 20-40%, which GM-CSF and IL-3 showed a significantly increased toxicity for Ara-C only.	Daunorubicin	53-65	colony stimulating factor 3	Homo sapiens	0-5